Skip to main content
Caplight Logo









HEPTA Medical

HEPTA Medical

Private
SuresnesHealthcare & Life Scienceshttps://www.heptamed.com/

Last Round

Series A

Sep 3, 2024

Total Funding Raised

$6.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

HEPTA Medical is a medical device company that develops a microwave ablation platform for the minimally invasive treatment of early-stage lung cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

microwave ablationlung cancer treatmentminimally invasive surgeryinterventional pulmonologyablation probemedical devicethermal ablationclinical decision supportprocedural visualizationpulmonary nodule treatmentmedtechendobronchial proceduremedical AIsurgical roboticsdigital surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HEPTA Medical Comparables

Compare HEPTA Medical with similar companies based on industry and business-model similarity.

HEPTA Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Endowave
83%
Broncus Medical
78%
Creo Medical Group PLC
74%

HEPTA Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 3, 2024

Key People

Founding team and executive leadership

Cécile Dupont Redon

President (previously CEO)

Executive Team

Thomas Bancel

Chief Executive Officer

Executive Team

HEPTA Medical Investors

Notable investors and investment history

HEPTA Medical investors
InvestorRounds
Sofinnova PartnersAccelerator
MD StartAccelerator
M&L Healthcare InvestmentsSeries A
BpifranceSeries A
ClérySeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 25, 2026

    Grew 25% quarter-over-quarter, from 12 to 15 employees.

  • May 18, 2026

    Grew 36% QoQ, from 11 to 15 employees.

HEPTA Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HEPTA Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HEPTA Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSuresnes
Employee Range16
Year Founded2019
Last FundingSep 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?